An absorbent article, the absorbent article being a personal hygiene article, includes a liquid permeable top sheet, a liquid impermeable back sheet, an absorbent core enclosed between the top sheet and the back sheet, and a fluid flow control member arranged between the top sheet and the backsheet. The fluid flow control member is a spacer fabric having a basis weight of 150-300 gsm and including a top layer, a bottom layer and an interconnecting layer of pile filaments between the top layer and the bottom layer. The pile filaments have a fineness of 80-130 dtex and the density of pile filament connections is 50-150/cm.sup.2.

A multi-use intravenous infusion assembly is presented which includes a septum actuator having various features to prevent over-insertion of the septum actuator through a slit in a blood control septum. By preventing over-insertion of the septum actuator, the slit of the septum is able to repeatedly self-close following removal of an external Luer device. Thus, the intravenous infusion assembly may be used repeatedly without exposing a clinician to blood and other infusion fluids.

A wound treatment appliance is provided for treating all or a portion of a wound. In some embodiments, the appliance includes an impermeable flexible overlay for applying a reduced pressure to the covered portion of the wound. The wound treatment appliance may also include a vacuum system to supply reduced pressure to the wound in the area under the flexible overlay, a wound packing means to prevent overgrowth of the wound or to encourage growth of the wound tissue into an absorbable matrix including the wound packing means, a suction drain, a collection chamber to collect and store exudate from the wound, and/or a suction bulb which may be used to provide a source of reduced pressure to an impermeable overlay that covers all or a portion of the wound. Finally, methods are provided for using various embodiments of the wound treatment appliance.

The present technology relates generally to a method and device for closing percutaneous punctures, and more particularly to a multi-lumen tamper for such a device. A closure device for sealing a percutaneous puncture in a wall of a body passageway is disclosed, the closure device including a plug configured to engage a surface of the puncture; a toggle configured to engage an internal surface of the body passageway; an elongate filament configured to associate the plug with the toggle; a locking member configured to engage the plug; and a tamper comprising at least two lumens, wherein a first lumen of the at least two lumens is configured to deliver a pharmaceutical agent to the plug.

The present technology relates generally to a method and device for closing percutaneous punctures, and more particularly to a multi-lumen tamper for such a device. A closure device for sealing a percutaneous puncture in a wall of a body passageway is disclosed, the closure device including a plug configured to engage a surface of the puncture; a toggle configured to engage an internal surface of the body passageway; an elongate filament configured to associate the plug with the toggle; a locking member configured to engage the plug; and a tamper comprising at least two lumens, wherein a first lumen of the at least two lumens is configured to deliver a pharmaceutical agent to the plug.

In alternative embodiments, the invention provides compositions, e.g., formulations, used for gastric, gastrointestinal and/or colonic treatments or lavage, e.g., orthostatic lavage, e.g., for inducing the purgation (e.g., cleansing) of a gastrointestinal (GI) tract, including a colon; and methods for making and using them. In alternative embodiments, compositions and methods of the invention are used for the stabilization, amelioration, treatment and/or prevention of constipation, for the treatment of abdominal pain, particularly non-specific abdominal pain, and diarrhea, including diarrhea caused by a drug side effect, a psychological condition, a disease or a condition such as Crohn's Disease, a poison, a toxin or an infection, e.g., a toxin-mediated traveler's diarrhea, or C. difficile or the pseudo-membranous colitis associated with this infection. In alternative embodiments, the invention provides pharmaceuticals and products (articles) of manufacture for delivering these compositions and formulations to an individual, e.g., a human or an animal. The invention also provides devices for delivering a fecal material to a patient.

A medical drainage tube for transporting liquid from a liquid source to a liquid storage device, the medical drainage tube includes an inner surface which defines a lumen; an inlet for coupling to a liquid source and for receiving liquid into the lumen from the liquid source; an outlet for coupling to a liquid storage device and for transporting the received liquid from the lumen to the liquid storage device; and an indicator including an indicating agent which, when the medical drainage tube is in use, is configured to dissolve after being exposed to the liquid for at least 24 hours, thereby providing a trigger which notifies a user that the medical drainage tube requires replacement.

A stapling assembly for use with a surgical stapler is disclosed. The stapling assembly comprises a first jaw, a second jaw, an elongate channel configured to receive a staple cartridge, a firing member, and a lockout. The staple cartridge comprises a sled configured to eject staples. The firing member is configured to move distally in response to a rotary motion. The firing member is configured to advance the sled during a firing stroke. The lockout is configured to selectively prevent said firing member from performing said firing stroke.

Disclosed is septum arrangement having a pierceable septum. The pierceable septum has first and second surfaces positioned opposite to one another and a peripheral surface. A compression element has at least two compression members that partially or fully surround the peripheral surface and has at least two gripping members. Each compression member is connected to at least one gripping member, and the gripping members extend from the compression members towards a common axis (A) which intersects the first surface. A resilient element exerts a biasing force on the pierceable septum that is directed towards the common axis (A). The gripping members define an aperture between them such that introduction of a needle into the aperture exerts a force on the gripping members that counteracts the biasing force and moves the gripping members apart from each other.

Anti-snagging components for use in infusion sets are provided. The anti-snagging component includes a sliding surface that guides an infusion set component past an obstruction when the infusion set is moved during manufacture or use. An anti-snagging structure may be integrally formed as a portion of an infusion set component or the anti-snagging structure may be a separate component that connects or attaches to an infusion set component. Some anti-snagging structures include a covering portion to cover a needleless connector and a tail portion to connect to a length of tubing. The covering portion may include an anti-microbial coating.